GU Cancers 2020 | GU 2020 PC highlights: CHHip & STAMPEDE

Name: GU 2020 PC highlights: CHHip & STAMPEDE
Uploaded: 2020-02-15T23:24:33Z
Description: Nicholas James, MBBS, PhD, FRCP, FRCR, The Institute of Cancer Research, London, UK, gives his prostate cancer highlights of the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA. These include UK data from the CHHiP (NCT00392535) and STAMPEDE (NCT00268476) trials, as well as new developments in molecular sub-typing that will allow more personalized patient care.

Nicholas James • 15 Feb 2020

GU Cancers 2020

Genitourinary Cancer Prostate Cancer Abiraterone Docetaxel Enzalutamide

CHHip STAMPEDE

Nicholas James, MBBS, PhD, FRCP, FRCR, The Institute of Cancer Research, London, UK, gives his prostate cancer highlights of the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA. These include UK data from the CHHiP (NCT00392535) and STAMPEDE (NCT00268476) trials, as well as new developments in molecular sub-typing that will allow more personalized patient care.